Valisure develops and applies novel technology based on laser-induced, quantum shift emissions to address the variability and quality problems that pervade many pharmaceutical products throughout the US. Valisure’s state-of-the-art system will enable consumers to receive medications that have all been pre-screened and validated, ensuring quality and consistency for patients.
Friends since their Yale days, founders Adam Clark-Joseph and David Light reconnected after Adam suffered serious complications caused by batch variability of his anticonvulsant medication. Shocked that no safe guards were in place, or even available, to prevent this from happening again, he was determined to resolve this issue. Adam reached out to David, who had a deep background in technology development, to help identify a solution. Upon further research, they began to grasp the magnitude and pervasiveness of the problem throughout the pharmaceutical industry. Adam and David brought together a team of like-minded scientists, entrepreneurs, and experts to develop and deploy a solution. The result was Valisure, a company that can ensure no one will have to suffer the adverse effects of subpar medications.